Management of newly diagnosed acute myeloid leukemia (AML) in patients deemed unfit for intensive chemotherapy is undergoing rapid transformation toward highly individualized regimens. The combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback